According to Alembic Pharmaceuticals's latest financial reports the company's current earnings are $0.78 Billion USD. In 2024 the company made an earning of $90.74 Million USD, an increase over its 2023 earnings that were of $75.52 Million USD. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2025 (TTM) | $92.82 M | 2.29% |
2024 | $90.74 M | 20.16% |
2023 | $75.52 M | 91.88% |
2022 | $39.35 M | -67.25% |
2021 | $0.12 B | -34.37% |
2020 | $0.18 B | 42.52% |
2019 | $0.12 B | 17.93% |
2018 | $0.10 B | 36.48% |
2017 | $79.84 M | -1.14% |
2016 | $80.75 M | -42% |
2015 | $0.13 B | 140.61% |
2014 | $57.86 M | 13.77% |
2013 | $50.86 M |